on SENSORION (EPA:ALSEN)
Results of the Sensorion General Meeting
On May 13, 2026, Sensorion, a pioneering biotechnology company focused on hearing therapies, announced the results of its Combined General Meeting of Shareholders. Held on May 11, 2026, the Meeting saw the adoption of all resolutions recommended by the Board of Directors. 77.83% of voting rights and share capital were represented.
Details of the votes on each resolution are available on the company's website, in the governance section. This General Meeting reinforced Sensorion's strategic objectives, focused on the development of gene therapies and small molecules to treat hearing loss.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SENSORION news